Evidence map›Paper›PMID 39968524›Full record

ArticleMaterials today. Bio2025

Multifunctional liposome boosts glioma ferroptosis and immunotherapy through reinforcement of chemo-dynamic therapy strategy.

Hongwu Chen, Jiehao Huang, Huaiming Wang, Yimin Xu, Jieling Chen, Tingting Deng, Zhongjing Su, Rui Lin, Cong Huang, Jie Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hongwu ChenShantou University Medical College, Shantou, 515041, China.
Jiehao HuangShantou University Medical College, Shantou, 515041, China.
Huaiming WangThe First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, China.
Yimin XuThe First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, China.
Jieling ChenShantou University Medical College, Shantou, 515041, China.
Tingting DengShantou University Medical College, Shantou, 515041, China.
Zhongjing SuShantou University Medical College, Shantou, 515041, China.
Rui LinThe First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, China.
Cong HuangThe First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, China.
Jie WuShantou University Medical College, Shantou, 515041, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioma remains significant challenging to completely cure by the conventional surgical resection because of its high infiltrative growth properties. Recently, emerging immunotherapy has achieved remarkable success in treating various cancer, but glioma do not benefit from cancer immunotherapy owing to its specific immunosuppressive tumor microenvironment (iTME). Herein, we show the significant improvement of the immunotherapy efficacy for glioma through multifunctional liposome (Lpo@Cu

Indexed as

Chemo-dynamic therapyFerroptosisGliomaImmunotherapyLiposome

Identifiers

PMID39968524
PMCPMC11834134

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.